DFC

Cidara Therapeutics Presents Promising New Data on Novel Drug-Fc Conjugate Candidates at the American Association for Cancer Research (AACR) Annual Meeting 2024

Retrieved on: 
Friday, April 5, 2024
CDTX, Colorectal cancer, Drug, Adenosine, Patient, SAN, Tavarua, AACR, Therapy, Cancer, Pathology, CCR5, CD73, DFC, San Diego Convention Center, Oleclumab, Escape Room, Vaccine

SAN DIEGO, April 05, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, announced the company will deliver four poster presentations, including one late-breaking poster presentation, at this year’s American Association for Cancer Research (AACR) Annual Meeting being held April 5-10, 2024 at the San Diego Convention Center in San Diego, California. The presentations highlight data on the company’s multispecific CD73/PD-1 drug Fc-conjugate (DFC), its CCR5-targeting DFC, and CBO421, its lead oncology DFC candidate targeting CD73.

Key Points: 
  • The presentations highlight data on the company’s multispecific CD73/PD-1 drug Fc-conjugate (DFC), its CCR5-targeting DFC, and CBO421, its lead oncology DFC candidate targeting CD73.
  • “Our Cloudbreak platform has quickly produced DFC candidates effective in preclinical studies across various cancers with specific disease targets.
  • This week, we are sharing data on our CCR5 DFC program for the first time, which has demonstrated robust efficacy as a monotherapy in mouse models of colorectal cancer.
  • Targeting CCR5 has the potential to improve response rates to immune checkpoint inhibitor therapies, which could have a greater impact for patients unresponsive to these current treatment options.

WTW announces USAID funding for transformative climate finance solution to scale up adaptation investment in vulnerable countries

Retrieved on: 
Monday, March 18, 2024
Climate change, Pressure, Development, USAID, Adaptation, Private sector, International development, WTW, EDGE, United, DFC, Bank

With USAID funding, WTW will design a pilot facility enabling the U.S. Development Finance Corporation (DFC) to offer a parametric insurance solution (Resilience Wrapper) that protects its direct loans to private enterprises from climate-related shocks.

Key Points: 
  • With USAID funding, WTW will design a pilot facility enabling the U.S. Development Finance Corporation (DFC) to offer a parametric insurance solution (Resilience Wrapper) that protects its direct loans to private enterprises from climate-related shocks.
  • Following a triggering event (such as a cyclone, flood, or drought), the subsequent loan repayment will be covered by the insurance payout.
  • In support of the President’s Emergency Plan for Adaptation and Resilience (PREPARE), the short-term catalytic funding was awarded through the USAID Climate Finance for Development Accelerator’s Adaptation Finance Window initiative.
  • I commend WTW's leadership in this area as it signals both the need and the opportunity for greater private investment in resilience.”

Adenia Closes Fifth Flagship Fund Oversubscribed at $470M

Retrieved on: 
Wednesday, April 3, 2024
Banking, Professional Services, Finance, Professional, DEG, DFI, Partner, Growth, Partner (business rank), Health, Education, ESG, Canari noir, Acquisition, AC, Investment, FMO, Air Liquide, Renewable energy, EIB, Telecommunications, Fund, DFC, CEP

Adenia Partners (“Adenia”), a leading private equity firm focused on growth opportunities in Africa, has successfully closed its fifth fund, Adenia Capital V (the “Fund”, “AC(V)” or “Fund V”) at its $470 million hard cap.

Key Points: 
  • Adenia Partners (“Adenia”), a leading private equity firm focused on growth opportunities in Africa, has successfully closed its fifth fund, Adenia Capital V (the “Fund”, “AC(V)” or “Fund V”) at its $470 million hard cap.
  • The Fund, which was significantly oversubscribed, attracted commitments from new and existing investors globally.
  • The Fund is sector-agnostic with financial services, agribusiness, renewable energy, consumer goods, telecommunications, healthcare and education, business services, light manufacturing, and specialty distribution as areas of particular focus.
  • As Adenia’s first completely pan-African fund, Fund V will leverage the firm’s extensive on-the-ground presence with seven offices on the continent.

DFC 4000 HybriDynamic Brake Pads: Bridging the Gap - Beyond Better, Approaching Best

Retrieved on: 
Monday, April 1, 2024
Dino Crescentini, Noise, Philosophy, Gap, Dust, Safety, DFC, Engineering, Road

LOS ANGELES, April 1, 2024 /PRNewswire/ -- Dynamic Friction Company (DFC) proudly unveils the DFC 4000 HybriDynamic Brake Pads, a groundbreaking addition to the world of brake technology.

Key Points: 
  • LOS ANGELES, April 1, 2024 /PRNewswire/ -- Dynamic Friction Company (DFC) proudly unveils the DFC 4000 HybriDynamic Brake Pads, a groundbreaking addition to the world of brake technology.
  • DFC 4000 HybriDynamic Brake Pads: Bridging the Gap - Beyond Better, Approaching Best
    Central to the DFC 4000 Brake Pads is the HybriDynamic Formulation, a bespoke amalgamation of ceramic and semi-metallic materials meticulously engineered to meet the specific requirements of each vehicle.
  • Advanced Stopping Power: Featuring our innovative HybriDynamic Formulation, the DFC 4000 Brake Pads deliver unmatched stopping capabilities, enhancing safety and response in all driving scenarios.
  • We invite you to experience the revolutionary DFC 4000 HybriDynamic Brake Pads, a symbol of our innovative approach to braking technology.

Akeyless named among "Tomorrow's Growth Companies" driving innovation and impact

Retrieved on: 
Wednesday, March 13, 2024
Culture, Software as a service, Growth, Indian stock exchange, Taboola, DevOps, DFC, Technology Center, TEL, Tech

NEW YORK and TEL AVIV, Israel, March 13, 2024 /PRNewswire/ -- Akeyless Security, the leader in Vaultless Secrets Management, was selected among eleven extraordinary tech companies as "Tomorrow's Growth Companies'' at Mind the Tech NY conference last week. This prestigious award is a testament to the culture and customer centricity at Akeyless since its inception. Akeyless is the preferred solution for managing credentials, certificates and keys in cloud and DevOps environments by numerous Fortune 500 companies including two of the Fortune five. Rooted in Israel's celebrated cybersecurity ecosystem, the company boasts a go-to-market headquarters in New York City and a Technology Center in Tel Aviv, embodying Israeli global innovation.

Key Points: 
  • This prestigious award is a testament to the culture and customer centricity at Akeyless since its inception.
  • Akeyless is the preferred solution for managing credentials, certificates and keys in cloud and DevOps environments by numerous Fortune 500 companies including two of the Fortune five.
  • "We're honored and thankful to be recognized for this prestigious award," said Oded Hareven, CEO and co-founder of Akeyless.
  • To learn more about Akeyless and how it's transforming secrets management for enterprises globally, visit www.akeyless.io .You can also learn more about Qumra capital at www.qumracapital.com/

Cidara Therapeutics to Present Preclincal Data on Multiple Novel Drug-Fc Conjugate Candidates at American Association dor Cancer Research (AACR) Annual Meeting 2024

Retrieved on: 
Wednesday, March 6, 2024
SAN, CDTX, AACR, Therapy, Abstract, Patient, Drug, San Diego Convention Center, DFC, Colorectal cancer, CCR5

SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced the company will be presenting three abstracts and one late-breaking abstract during the American Association for Cancer Research (AACR) Annual Meeting to be held April 5-10, 2024 at the San Diego Convention Center in San Diego, California.

Key Points: 
  • SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced the company will be presenting three abstracts and one late-breaking abstract during the American Association for Cancer Research (AACR) Annual Meeting to be held April 5-10, 2024 at the San Diego Convention Center in San Diego, California.
  • Presentation details are summarized below:
    Abstract Title: CCR5-001, a novel Drug Fc-Conjugate (DFC) targeting CCR5, demonstrates potent efficacy in a colorectal cancer mouse model
    Presenters: Elizabeth Abelovski and Nicholas Dedeic, Ph.D.

Open Society Foundations’ Soros Economic Development Fund Commits $25 Million to Allied Climate Partners’ Climate Finance Partnership

Retrieved on: 
Tuesday, February 27, 2024
Acquisition, George Soros, International Finance Corporation, African Development Bank, Foreign direct investment, Jeff Bezos, British International Investment, FMO, BII, Risk, World Bank Group, Open Society Foundations, DFI, ACP, DFC, Partnership, Renewable energy

New York, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The Soros Economic Development Fund (SEDF), the impact investment arm of the Open Society Foundations, is committing $25 million to Allied Climate Partners (ACP)—a new and innovative public-private partnership focused on increasing the number of bankable climate projects in emerging markets and developing economies around the world.

Key Points: 
  • New York, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The Soros Economic Development Fund (SEDF), the impact investment arm of the Open Society Foundations, is committing $25 million to Allied Climate Partners (ACP)—a new and innovative public-private partnership focused on increasing the number of bankable climate projects in emerging markets and developing economies around the world.
  • ACP aims to address a critical financing gap at the early, risk-oriented stages of the development process.
  • Without this support, many projects and businesses struggle to attract the necessary capital to achieve their climate-related goals.
  • These regional funds will in turn seek to raise an additional $600+ million in senior equity from multilateral development banks (MDBs), development finance institutions (DFIs), and private investors.

Niyam Announces Courtney Robertson as Senior Director, Strategic Accounts

Retrieved on: 
Thursday, March 7, 2024
Acquisition, Bangladesh Technical Education Board, Division, GSA, Food and Drug Administration, Federal Bureau of Investigation, National Institutes of Health, NIH, FEMA, FDA, DHS, Food, National security, Federation, Climate change, EPMD, NFIP, FBI, General Services Administration, LCCE, PMO, DFC, Information technology, Pivot, Bottled water

LEESBURG, Va., March 7, 2024 /PRNewswire/ -- Niyam IT , a leading solutions provider and a fast-growing IT services company delivering innovative solutions to the federal government, specifically for the National Security segment, today announced Courtney Robertson has been named the company's Senior Director, Strategic Accounts.

Key Points: 
  • LEESBURG, Va., March 7, 2024 /PRNewswire/ -- Niyam IT , a leading solutions provider and a fast-growing IT services company delivering innovative solutions to the federal government, specifically for the National Security segment, today announced Courtney Robertson has been named the company's Senior Director, Strategic Accounts.
  • "Courtney's experience with FEMA inflicting strategic change and spearheading successful modernization efforts will be invaluable," said Raj Parameswaran, President and COO, Niyam.
  • "I'm looking forward to the opportunity to work with Courtney again," said Suman Biswas, Founder and CEO, Niyam.
  • "I believe his addition to Niyam will put us on an upward growth trajectory for years to come and be a valued partner of FEMA ."

American, Finnish and Canadian governments fund oxygen plant at Tatu City SEZ, Kenya

Retrieved on: 
Wednesday, March 6, 2024
Oxygen, George Soros, Davis & Shirtliff, Woman, Ministry, Student, Transport, Pneumonia, Grand Challenges Canada, Pregnancy, Heineken, Ministry of Health, Organization, COVID, CCI, Child, DFC, Mortality, Pharmaceutical industry

TATU CITY, Kenya, March 6, 2024 /PRNewswire/ -- The governments of the United States, Finland and Canada are funding a sustainable, accessible and affordable medicinal oxygen manufacturing facility at Tatu City Special Economic Zone (SEZ), the 5,000-acre new city on Nairobi's doorstep.

Key Points: 
  • TATU CITY, Kenya, March 6, 2024 /PRNewswire/ -- The governments of the United States, Finland and Canada are funding a sustainable, accessible and affordable medicinal oxygen manufacturing facility at Tatu City Special Economic Zone (SEZ), the 5,000-acre new city on Nairobi's doorstep.
  • Hewatele will use the debt and equity funds raised to finance the building of a cutting-edge Cryogenic Medical Liquid Oxygen Air Separation Unit plant at Tatu Industrial Park.
  • Dr Bernard Olayo, Founder of Hewatele, said: "This medical oxygen plant represents a significant leap in ensuring sustainable and affordable access to medicinal oxygen.
  • The increased production capacity here at Tatu City will improve oxygen affordability, particularly for maternal and child healthcare, and enhance primary healthcare support."

American, Finnish and Canadian governments fund oxygen plant at Tatu City SEZ, Kenya

Retrieved on: 
Wednesday, March 6, 2024
Oxygen, George Soros, Davis & Shirtliff, Woman, Ministry, Student, Transport, Pneumonia, Grand Challenges Canada, Pregnancy, Heineken, Ministry of Health, Organization, COVID, CCI, Child, DFC, Mortality, Pharmaceutical industry

TATU CITY, Kenya, March 6, 2024 /PRNewswire/ -- The governments of the United States, Finland and Canada are funding a sustainable, accessible and affordable medicinal oxygen manufacturing facility at Tatu City Special Economic Zone (SEZ), the 5,000-acre new city on Nairobi's doorstep.

Key Points: 
  • TATU CITY, Kenya, March 6, 2024 /PRNewswire/ -- The governments of the United States, Finland and Canada are funding a sustainable, accessible and affordable medicinal oxygen manufacturing facility at Tatu City Special Economic Zone (SEZ), the 5,000-acre new city on Nairobi's doorstep.
  • Hewatele will use the debt and equity funds raised to finance the building of a cutting-edge Cryogenic Medical Liquid Oxygen Air Separation Unit plant at Tatu Industrial Park.
  • Dr Bernard Olayo, Founder of Hewatele, said: "This medical oxygen plant represents a significant leap in ensuring sustainable and affordable access to medicinal oxygen.
  • The increased production capacity here at Tatu City will improve oxygen affordability, particularly for maternal and child healthcare, and enhance primary healthcare support."